Implications of adipocyte dysfunction in pediatric obesity: a narrative review

Pediatr Endocrinol Diabetes Metab. 2026;32(2):121-128. doi: 10.5114/pedm.2026.161340.ABSTRACTObesity is a significant inflammatory disease that has become increasingly prevalent among children from different ethnic groups. Lifestyle choices, diet, and maternal obesity are key contributors to its dev

I Isabela Sallati

Increasing burden of multiple long-term conditions and mortality risk following COVID-19 diagnosis: a national cohort study of one million adults with cardiovascular disease in England

J Public Health (Oxf). 2026 Sep 7:fdag062. doi: 10.1093/pubmed/fdag062. Online ahead of print.ABSTRACTBACKGROUND: Individuals with cardiovascular disease (CVD) experienced high mortality during coronavirus disease 2019 (COVID-19), yet most live with multiple long-term conditions (MLTCs). We examined

Y Yogini V Chudasama

Uric Acid and Cardiovascular Disease

Cardiol Rev. 2026 Sep 7. doi: 10.1097/CRD.0000000000001460. Online ahead of print.ABSTRACTHyperuricemia, a major metabolic abnormality following hyperglycemia, hypertension, and hyperlipidemia, represents a significant global public health issue. Complex pathological mechanisms can lead to hyperuric

A Antonis A Manolis

Influence of Ageing on the Pharmacology, Efficacy and Safety of Oral Targeted Therapies for Inflammatory Bowel Disease: Focus on Janus Kinase (JAK) Inhibitors and Sphingosine-1-Phosphate (S1P) Receptor Modulators

Drugs Aging. 2026 Sep 7. doi: 10.1007/s40266-026-01321-w. Online ahead of print.ABSTRACTOlder adults represent a rapidly expanding subgroup of patients with inflammatory bowel disease, yet they remain markedly under-represented in pivotal clinical trials, limiting age-specific estimates of drug bene

L Luc J J Derijks

Efficacy and Safety of Fixed-Dose Combination Therapy with Cilostazol and Rosuvastatin in Patients with Symptomatic Lower Extremity Peripheral Artery Disease: A Multicenter Randomized Controlled Trial

Cardiovasc Drugs Ther. 2026 Sep 7. doi: 10.1007/s10557-026-07951-x. Online ahead of print.ABSTRACTPURPOSE: To evaluate whether combined cilostazol and rosuvastatin therapy improves health-related quality of life, walking performance, and lipid profiles compared with rosuvastatin alone in patients wi

A Adelin Dhivi Kemalasari

Innovation and Challenges in Materials for Transcatheter Aortic Valves

J Cardiovasc Transl Res. 2026 Sep 5;19(1):111. doi: 10.1007/s12265-026-10840-1.ABSTRACTTranscatheter Aortic valve implantation (TAVI) procedure has been revolutionizing the Aortic Stenosis (AS) treatment over the last 20 years, because of its minimally invasive approach and fast postoperative recove

P Pramod Dorishetty

Tempol Attenuates Diabetes-induced Transcriptomic Changes in the Rat Retina

Mol Neurobiol. 2026 Sep 7;63(1):881. doi: 10.1007/s12035-026-06186-z.ABSTRACTDiabetic retinopathy (DR) is a common late-stage complication of diabetes and a leading cause of vision loss. Oxidative stress plays a crucial role in DR progression by activating stress pathways and altering gene expressio

H Heba Al-Hussaini